Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody Jan 23, 2020 Life Science
Mycovia Pharmaceuticals Expands Commercialization Team with Strategic New Hires Jan 21, 2020 Life Science
Pharma Companies Cut Prices of Off-Patent Drugs to Compete in China’s Bulk-Buy Program Jan 20, 2020 Life Science
Healthcare Roundup – FDA OK generic version of Lilly’s Jardiance, Endra re-ups with GE Healthcare Jan 15, 2020 Life Science
Ambrx and Sino Biopharma Announce Collaboration to Develop Two Next-Generation Biologics Jan 13, 2020 Life Science
CStone completes registration filing for the Phase I trial of its tumor immune microenvironment modulator CS3005 to enable study initiation in Australia Dec 12, 2019 Life Science
Replicel Provides Update to Private Placement Financing of Preferred Shares Oct 11, 2019 Life Science
Replicel Closes First Tranche of Private Placement Financing of Preferred Shares Sep 13, 2019 Life Science
Genenta Science of Milan Raises $14.6 Million in Funding Led by China Investor Sep 13, 2019 Life Science
RepliCel’s Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China Sep 11, 2019 Life Science
